Exane Derivatives’s Bank of America BAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-35,282
| Closed | -$1.45M | – | 797 |
|
|
2022
Q1 | $1.45M | Sell |
35,282
-18,265
| -34% | -$824K | 0.41% | 52 |
|
|
2021
Q4 | $2.38M | Sell |
53,547
-6,942
| -11% | -$316K | 0.58% | 30 |
|
|
2021
Q3 | $2.57M | Sell |
60,489
-2,337
| -4% | -$94.1K | 0.62% | 27 |
|
|
2021
Q2 | $2.5M | Buy |
+62,826
| New | +$2.58M | 0.57% | 29 |
|
|
2021
Q1 | – | Sell |
-39,916
| Closed | -$1.21M | – | 917 |
|
|
2020
Q4 | $1.21M | Buy |
39,916
+787
| +2% | +$21.1K | 0.36% | 60 |
|
|
2020
Q3 | $943K | Sell |
39,129
-16,607
| -30% | -$413K | 0.27% | 91 |
|
|
2020
Q2 | $1.32M | Sell |
55,736
-5,272
| -9% | -$125K | 0.35% | 77 |
|
|
2020
Q1 | $1.3M | Sell |
61,008
-7,206
| -11% | -$216K | 0.36% | 68 |
|
|
2019
Q4 | $2.36M | Buy |
68,214
+6,785
| +11% | +$219K | 0.44% | 73 |
|
|
2019
Q3 | $1.79M | Sell |
61,429
-5,707
| -9% | -$164K | 0.32% | 74 |
|
|
2019
Q2 | $1.95M | Buy |
+67,136
| New | +$1.94M | 0.34% | 71 |
|
|
2019
Q1 | – | Sell |
-61,864
| Closed | -$1.52M | – | 669 |
|
|
2018
Q4 | $1.52M | Sell |
61,864
-29,015
| -32% | -$787K | 0.27% | 89 |
|
|
2018
Q3 | $2.68M | Buy |
90,879
+24,767
| +37% | +$754K | 0.5% | 65 |
|
|
2018
Q2 | $1.86M | Sell |
66,112
-4,486
| -6% | -$134K | 0.31% | 76 |
|
|
2018
Q1 | $2.07M | Buy |
70,598
+10,399
| +17% | +$327K | 0.42% | 67 |
|
|
2017
Q4 | $1.78M | Buy |
60,199
+761
| +1% | +$21K | 0.31% | 53 |
|
|
2017
Q3 | $1.51M | Buy |
59,438
+1,678
| +3% | +$40.7K | 0.28% | 66 |
|
|
2017
Q2 | $1.4M | Buy |
57,760
+6,207
| +12% | +$145K | 0.3% | 79 |
|
|
2017
Q1 | $1.22M | Sell |
51,553
-950
| -2% | -$22.5K | 0.28% | 84 |
|
|
2016
Q4 | $1.16M | Buy |
52,503
+7,389
| +16% | +$142K | 0.23% | 82 |
|
|
2016
Q3 | $706K | Sell |
45,114
-33,042
| -42% | -$492K | 0.11% | 131 |
|
|
2016
Q2 | $1.04M | Buy |
78,156
+35,438
| +83% | +$498K | 0.17% | 86 |
|
|
2016
Q1 | $578K | Buy |
+42,718
| New | +$577K | 0.08% | 127 |
|
|
2015
Q4 | – | Sell |
-38,761
| Closed | -$604K | – | 524 |
|
|
2015
Q3 | $604K | Buy |
38,761
+25,018
| +182% | +$421K | 0.08% | 113 |
|
|
2015
Q2 | $234K | Sell |
13,743
-100,342
| -88% | -$1.65M | 0.03% | 200 |
|
|
2015
Q1 | $1.76M | Buy |
114,085
+64,728
| +131% | +$1.04M | 0.19% | 69 |
|
|
2014
Q4 | $883K | Buy |
+49,357
| New | +$845K | 0.12% | 101 |
|
Other funds holding BAC
Exane Derivatives's BAC Position: Q2 2022 in Review
Exane Derivatives sold out of Bank of America (BAC) in Q2 2022, closing a stake of 35,282 shares — an estimated $1.45M sold.
Exane Derivatives first reported a position in BAC in Q4 2014 and held it in 27 quarters. The position peaked at $2.68M in Q3 2018. 2,641 funds tracked by Wall St. Rank hold BAC as of Q2 2022.
- Exane Derivatives reported no remaining Bank of America position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 35,282 Bank of America shares in Q2 2022, an estimated $1.45M.
- Exane Derivatives first reported a position in Bank of America in Q4 2014 and held it in 27 quarters.
- Exane Derivatives's Bank of America position peaked at $2.68M in Q3 2018.
- 2,641 funds tracked by Wall St. Rank held Bank of America as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.